News
-
-
-
COMMUNIQUÉ DE PRESSE
Topadur Pharma AG Adds Senior Board Expertise with Appointment of Dr. Felix R. Ehrat and Dr. Peter Jager
Topadur Pharma AG appoints Dr. Felix R. Ehrat and Dr. Peter Jager to its Board of Directors, adding strategic expertise as the company advances clinical programs and prepares for growth -
-
-
COMMUNIQUÉ DE PRESSE
Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth
Topadur Pharma AG appoints Matthias Schäfer as Chief Executive Officer to lead company growth into next phase of clinical development and expansion. Dr. Reto Naef transitions to Senior Scientific Advisor
